Visual Function in Neurofibromatosis

Castanheira–Dinis, A.; Novais, M; Cravo, Isabel; Campos, Fátima; Gouveia-Andrade, L; Ribeiro-da-Silva, J.

doi:10.1097/00041327-199612000-00002

Cited by 10 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As anormalidades visuais e oculares em 75 pacientes com neurofibromatomatose foram revistas por Cas-tanheira-Dinis et al (18) . Anormalidades do olho e da órbita, incluindo nódulos de Lisch, gliomas das vias ópticas, opacidades do cristalino, hamartomas retinianos, displasia esfenoidal, e glaucoma congênito ocorreram em 42 (56%) dos pacientes.…”

Section: Tumores Do Nervo óPticounclassified

Neuro-Oftalmologia: sistema sensorial -- Parte II Revisão 1997 -- 1999

Lana-Peixoto

2002

Arq. Bras. Oftalmol.

View full text Add to dashboard Cite

Endereço para correspondência: Rua Padre Rolim, 769 -13 0 andar -Belo Horizonte (MG) CEP 30130-090. E-mail: lanapma@uol.com.br ATUALIZAÇÃO CONTINUADA Neuro-Ophthalmology. Sensorial system -Part II. Review 1997-1999 Neuro-Oftalmologia. Sistema sensorial -Parte II Revisão 1997Revisão -1999 Marco Aurélio Lana-PeixotoEsta é a segunda parte de uma revisão da literatura do sistema visual sensorial. O autor seleciona artigos publicados na literatura entre os anos de 1997 e 1999 relacionados a neurorretinites, neuropatia óptica compressiva, tumores do nervo óptico, pseudotumor cerebral, neuropatias ópticas hereditárias, hipoplasia do nervo óptico, drusas do disco óptico, neuropatia óptica tóxica, neuropatia óptica traumática, outras neuropatias ópticas e doenças retinianas, doenças do quiasma óptico e do trato óptico, assim como alterações geniculares e retrogeniculares, incluindo os distúrbios visuais corticais. Os artigos são apresentados e comentados quanto às suas conclusões, alcance e relações com o conhecimento previamente estabelecido.

show abstract

Section: Tumores Do Nervo óPticounclassified

Neuro-Oftalmologia: sistema sensorial -- Parte II Revisão 1997 -- 1999

Lana-Peixoto

2002

Arq. Bras. Oftalmol.

View full text Add to dashboard Cite

show abstract

“…Optic nerve gliomas usually develop by 10 years of age. Initial symptoms may include proptosis, decreased visual acuity, or precocious puberty (Castanheira-Dinis, et al, 1996). Visual examinations by an experienced ophthalmologist knowledgeable about neurofibromatosis is of utmost importance.…”

mentioning

confidence: 99%

Development and Implementation of a Carboplatin Desensitization Protocol for Children with Neurofibromatosis, Type 1 and Hypersensitivity Reactions in an Outpatient Oncology Clinic

Ogle

Rose

Wildes

2002

J Pediatr Oncol Nurs

View full text Add to dashboard Cite

Neurofibromatosis, type 1 (NF 1), is a relatively common disorder. Children with NF 1 are at much greater risk for the development of optic pathway tumors, which are sometimes treated with chemotherapy. As a result, many oncology centers and clinics are now seeing and treating NF patients. One of the most frequently used drugs is carboplatin. However, as many as 30% of NF patients may develop a reaction to carboplatin, which can include anaphylaxis. This often results in the cessation of the medication and treatment protocol. At the Children's Hospital of Philadelphia a desensitization protocol has been instituted with children who have had such reactions and whose tumors have demonstrated a positive response to the treatment. The desensitization process is quite complex and requires an interdisciplinary approach. However, it is the nursing personnel that are key to the successful coordination and delivery of such a protocol in an oncology outpatient clinic on a regular basis.

show abstract